Evotec SE to Announce Q3 2025 Results on November 5, 2025

miércoles, 29 de octubre de 2025, 5:14 am ET1 min de lectura
EVO--

Evotec SE will announce its interim statement for the first nine months of 2025 on November 5, 2025. The company will hold a conference call to discuss the results and provide an update on its performance. The conference call will be held in English and will be available via phone and webcast. Evotec is a life science company that integrates breakthrough science with AI-driven innovation and advanced technologies to accelerate drug discovery and development.

Evotec SE to Announce Q3 2025 Results on November 5, 2025

Comentarios



Add a public comment...
Sin comentarios

Aún no hay comentarios